103 related articles for article (PubMed ID: 23513803)
1. [Progress of molecular targeted therapies].
Hayashi H; Nishio K
Nihon Rinsho; 2012 Nov; 70 Suppl 8():7-11. PubMed ID: 23513803
[No Abstract] [Full Text] [Related]
2. [Future direction of medical oncology in Japan].
Nakagawa K
Nihon Rinsho; 2012 Nov; 70 Suppl 8():1-4. PubMed ID: 23513802
[No Abstract] [Full Text] [Related]
3. [Selection of a molecule-target agent--present and prospect].
Takahashi N; Hamaguchi T
Nihon Rinsho; 2011 Apr; 69 Suppl 3():482-6. PubMed ID: 22214008
[No Abstract] [Full Text] [Related]
4. Malignant pheochromocytoma and paraganglioma: future considerations for therapy.
Buzzoni R; Pusceddu S; Damato A; Meroni E; Aktolun C; Milione M; Mazzaferro V; De Braud F; Spreafico C; Maccauro M; Zaffaroni N; Castellani MR
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):153-60. PubMed ID: 23598685
[TBL] [Abstract][Full Text] [Related]
5. Personalizing oncology: perspectives and prospects.
Mendelsohn J
J Clin Oncol; 2013 May; 31(15):1904-11. PubMed ID: 23589547
[TBL] [Abstract][Full Text] [Related]
6. [Current treatment strategy of sex cord--stromal tumors of the ovary by molecular targeted therapy].
Watanabe Y; Ekawa Y; Hoshiai H
Nihon Rinsho; 2012 Jun; 70 Suppl 4():656-8. PubMed ID: 23156327
[No Abstract] [Full Text] [Related]
7. Advances in targeted therapies XIII.
Breedveld FC; Kalden JR; Smolen JS
Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i1. PubMed ID: 22460135
[No Abstract] [Full Text] [Related]
8. Genetic tumor profiling and genetically targeted cancer therapy.
Goetsch CM
Semin Oncol Nurs; 2011 Feb; 27(1):34-44. PubMed ID: 21255711
[TBL] [Abstract][Full Text] [Related]
9. [Targeted therapies: towards a new toxicology?].
Aissi S; Ben Mrad M; Zarraa S; Bounedjar A; Laabidi S; Boussen H
Pathol Biol (Paris); 2012 Aug; 60(4):234-8. PubMed ID: 22743098
[TBL] [Abstract][Full Text] [Related]
10. [Targeted based therapies in metastatic breast cancer: future evolution].
Belmondo L; Montana M; Curti C; Crozet M; Rathelot P; Penot-Ragon C; Vanelle P
Therapie; 2012; 67(6):491-503. PubMed ID: 23249575
[TBL] [Abstract][Full Text] [Related]
11. Targeted cancer therapies: current status and future directions.
Starakis I
Curr Med Chem; 2011; 18(11):1573-4. PubMed ID: 21428889
[No Abstract] [Full Text] [Related]
12. Targeting tyrosine kinases in cancer: the converging roles of cytopathology and molecular pathology in the era of genomic medicine.
Dumur CI; Idowu MO; Powers CN
Cancer Cytopathol; 2013 Feb; 121(2):61-71. PubMed ID: 22887782
[TBL] [Abstract][Full Text] [Related]
13. Advances in targeted therapies XII. Preface.
Breedveld FC; Kalden JR; Smolen JS
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i1. PubMed ID: 21339210
[No Abstract] [Full Text] [Related]
14. Emerging therapy in hemoglobinopathies: lessons from the past and optimism for the future.
Vichinsky EP
Hematol Oncol Clin North Am; 2014 Apr; 28(2):xiii-xviii. PubMed ID: 24589274
[No Abstract] [Full Text] [Related]
15. The evolution of bone-targeted therapies: introduction.
Gnant M
Semin Oncol; 2010 Oct; 37 Suppl 2():S1. PubMed ID: 21111243
[No Abstract] [Full Text] [Related]
16. [Biomarker research and molecular targeting therapy].
Nakagawa H
Nihon Rinsho; 2012 Nov; 70 Suppl 8():294-7. PubMed ID: 23513854
[No Abstract] [Full Text] [Related]
17. [Historical aspect of molecular-targeted therapy for cancer].
Sone S; Otsuka K; Tobiume M; Tada H
Nihon Rinsho; 2010 Oct; 68(10):1787-95. PubMed ID: 20954319
[TBL] [Abstract][Full Text] [Related]
18. [Clinical studies in oncology--a challenge for clinical and academic pathology].
Röcken C
Dtsch Med Wochenschr; 2013 May; 138(20):1073-6. PubMed ID: 23670265
[No Abstract] [Full Text] [Related]
19. Treatment of acute lung injury: time to think outside the box?
Miyata R; Van Eeden SF
Respiration; 2011; 81(1):6-8. PubMed ID: 20938167
[No Abstract] [Full Text] [Related]
20. [Pruritus : What is the future?].
Ständer S; Raap U
Hautarzt; 2016 Aug; 67(8):594. PubMed ID: 27306977
[No Abstract] [Full Text] [Related]
[Next] [New Search]
